Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 13/20 | 0.40 |
| ▸ | CCKAR | P32238 | 3/20 | 0.40 |
| ▸ | BDKRB1 | P46663 | 6/20 | 0.39 |
| ▸ | OXTR | P30559 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8537363 | 1.00 | CCKBR (0.40) | CCKBRCCKARBDKRB1OXTR | |
| SCHEMBL8532880 | 0.82 | BDKRB1 (0.44) | CCKBRCCKARBDKRB1OXTR | |
| SCHEMBL8532877 | 0.82 | BDKRB1 (0.44) | CCKBRCCKARBDKRB1OXTR | |
| SCHEMBL7547895 | 0.81 | TP53 (0.35) | CCKBROXTR | |
| SCHEMBL7547899 | 0.81 | TP53 (0.35) | CCKBROXTR | |
| SCHEMBL8535047 | 0.80 | BDKRB1 (0.41) | CCKBRCCKARBDKRB1OXTR | |
| SCHEMBL8535054 | 0.80 | BDKRB1 (0.41) | CCKBRCCKARBDKRB1OXTR | |
| SCHEMBL8537826 | 0.79 | CCKBR (0.44) | CCKBRCCKAR | |
| SCHEMBL8537821 | 0.79 | CCKBR (0.44) | CCKBRCCKAR | |
| SCHEMBL8538053 | 0.79 | CCKBR (0.68) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5763437-A | Benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-09 | — | — | US | disclosed |
| EP-0804425-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996004254-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |